Delphi Ventures

Delphi Ventures, established in 1988, stands as a pioneering venture capital firm with a dedicated focus on the life sciences sector. Based in San Mateo, California, the firm was among the first to specialize in this critical industry, building deep expertise over more than three decades. Its long-standing presence and specialized approach have allowed it to become a significant player in funding innovative healthcare and biotechnology companies, contributing to advancements in medicine and patient care.

The firm's investment strategy primarily targets early-stage companies, including Seed, Series A, and Series B rounds, though it also considers later-stage opportunities when compelling. Delphi Ventures often takes on the role of a lead investor or a substantial participant in financing rounds, demonstrating its commitment and belief in its portfolio companies. Initial investments typically range from $5 million to $15 million, with additional capital reserved for follow-on investments to support growth and development.

Delphi Ventures has successfully raised seven funds, accumulating over $1 billion in total committed capital. This substantial capital base enables the firm to provide robust financial backing to its portfolio. Their investments span a broad spectrum of the life sciences, encompassing therapeutics, medical devices, and diagnostics. The firm is known for its hands-on approach, leveraging its extensive network and industry knowledge to help guide portfolio companies from inception through commercialization, aiming to foster significant advancements in healthcare.